Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally do not reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson's, Alzheimer's, and Huntington's disease.
A Spanish hospital research group has developed a new composition to prevent, alleviate, ameliorate and treat diseases or disorders specially related to Parkinson's disease. The composition takes into account the relevant role of the enteric nervous system in the pathogenesis of Parkinson's disease (PD) and the connection between inflammatory intestinal diseases and bacterial flora. This connection supposes a new composition that consists of at least one aminosalicylate as active ingredient.
The use of the composition is preventive: the administration is carried out before the diagnosis of the disease, or in the first stages.
The research group is looking for the following collaboration:
-License agreement: framework of authorizing the interested parties to use the technology.
-Technical cooperation agreement: to collaborate with other research teams, companies or foundations.